Kidney Cancer

>

Latest News

Delays in All Organ Tumor Progression Observed in Lenvatinib/Pembrolizumab in Advanced RCC
Delays in All Organ Tumor Progression Observed in Lenvatinib/Pembrolizumab in Advanced RCC

June 5th 2024

“Our analysis showed that the time to progression was later with the use of lenvatinib and pembrolizumab compared with sunitinib,” said Viktor Grünwald, MD, PhD.

Pre-Treatment TILs Does Not Impact Nivolumab/Ipilimumab Therapy in mccRCC
Pre-Treatment TILs Does Not Impact Nivolumab/Ipilimumab Therapy in mccRCC

June 2nd 2024

Treatment with DFF332 appears to be safe and tolerable across all dose levels, according to Sumanta Kumar Pal, MD.
DFF332 Shows Potential Activity in Advanced Clear Cell RCC

June 1st 2024

Learning AE Management With Immunotherapy vs TKIs in RCC
Learning AE Management With Immunotherapy vs TKIs in RCC

May 22nd 2024

Scratching the Surface in Managing Advanced RCC
Scratching the Surface in Managing Advanced RCC

May 19th 2024

More News